Nicoderm Patch, Extended Release
Product Images NDC 0135-0196

4 FDA label images from Haleon Us Holdings Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicoderm (NDC 0135-0196). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Haleon Us Holdings Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

102838xb Nicoderm Cq 21 mg Opaque 14patches

102838xb Nicoderm Cq 21 mg Opaque 14patches
NicoDerm CQ 21 mg/24h nicotine transdermal patch extended-release packaging label. It shows an opaque patch with SMARTCONTROL technology for stop smoking aid. The label indicates Step 1 for smokers of more than 10 cigarettes per day and contains 14 opaque patches in a 2-week kit. The labeler is Haleon US Holdings LLC.*
FDA Label Image

106192xa Nicoderm Cq 21 mg 14 Patches.jpg.jpg.jpg

106192xa Nicoderm Cq 21 mg 14 Patches.jpg.jpg.jpg
Packaging label for NicoDerm CQ 21 mg/24h transdermal patch by Haleon US Holdings LLC. The box features a clear extended release nicotine patch with SmartControl Technology, containing 14 patches for a 2-week kit. The label highlights it as a stop smoking aid, specifying Step 1 for smokers of more than 10 cigarettes a day, with actual patch size shown. The GSK logo appears in the upper right corner.*
FDA Label Image

106194xa Nicoderm Cq 7 mg 14 Patches.jpg.jpg.jpg

106194xa Nicoderm Cq 7 mg 14 Patches.jpg.jpg.jpg
NICODERM CQ 7 mg/24h clear transdermal patch extended release packaging label. The label highlights it is a stop smoking aid with SmartControl technology, intended as Step 3 for use after completing Step 2. The package contains 14 clear patches in a 2-week kit. The labeler is Haleon US Holdings LLC.*
FDA Label Image

106195xa Nicoderm Cq 14 mg 14 Patches.jpg.jpg.jpg

106195xa Nicoderm Cq 14 mg 14 Patches.jpg.jpg.jpg
NICODERM CQ Nicotine Transdermal System 14 mg/24h clear patch extended release packaging label. It is a transdermal patch stop smoking aid with SmartControl technology, labeled as Step 2 for smokers who smoke 10 or fewer cigarettes a day. The package includes 14 clear patches intended as a 2-week kit. Labeler is Haleon US Holdings LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.